- BIOBUSINESS BRIEFS
2020 biotech IPOs shatter all the records
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature Reviews Drug Discovery 20, 93-94 (2021)
doi: https://doi.org/10.1038/d41573-021-00019-5
Competing Interests
RA Capital is a registered investment adviser. This article is not intended, and should not be construed as, investment advice or recommendation to invest in any security. Likewise, this article is not intended as a solicitation to invest in any RA Capital product or service. RA Capital may hold long and/or short positions in companies referenced. All companies mentioned were chosen based on their IPOs’ gross proceeds in the subgroups described.